Repository logo
 

Molecular basis of the human ribosomopathy Shwachman-Diamond syndrome

Published version
Peer-reviewed

Change log

Authors

Warren, AJ 

Abstract

Mutations that target the ubiquitous process of ribosome assembly paradoxically cause diverse tissue-specific disorders (ribosomopathies) that are often associated with an increased risk of cancer. Ribosomes are the essential macromolecular machines that read the genetic code in all cells in all kingdoms of life. Following pre-assembly in the nucleus, precursors of the large 60S and small 40S ribosomal subunits are exported to the cytoplasm where the final steps in maturation are completed. Here, I review the recent insights into the conserved mechanisms of ribosome assembly that have come from functional characterisation of the genes mutated in human ribosomopathies. In particular, recent advances in cryo-electron microscopy, coupled with genetic, biochemical and prior structural data, have revealed that the SBDS protein that is deficient in the inherited leukaemia predisposition disorder Shwachman-Diamond syndrome couples the final step in cytoplasmic 60S ribosomal subunit maturation to a quality control assessment of the structural and functional integrity of the nascent particle. Thus, study of this fascinating disorder is providing remarkable insights into how the large ribosomal subunit is functionally activated in the cytoplasm to enter the actively translating pool of ribosomes.

Description

Keywords

SBDS, DNAJC21, eIF6, Shwachman-Diamond syndrome, ribosome, myelodysplastic syndromes

Journal Title

Advances in Biological Regulation

Conference Name

Journal ISSN

2212-4926
2212-4934

Volume Title

67

Publisher

Elsevier
Sponsorship
Medical Research Council (MR/L003368/1)
Bloodwise (15035)
Wellcome Trust (100140/Z/12/Z)
Work in the Warren group is supported by a Specialist Programme from Bloodwise (12048 to A.J.W.), the UK Medical Research Council (MRC) (MC_U105161083 to A.J.W.), a Wellcome Trust strategic award to the Cambridge Institute for Medical Research (100140), a core support grant from the Wellcome Trust and MRC to the Wellcome Trust–Medical Research Council Cambridge Stem Cell Institute, Ted's Gang, the Connor Wright Shwachman-Diamond Project and the Cambridge National Institute for Health Research Biomedical Research Centre.